publication date: May. 5, 2017
Faculty Senate Chair Julie Izzo: MD Anderson has evolved beyond “autocratic structure”
Chair, Faculty Senate
Associate professor in Translational Molecular Pathology, MD Anderson Cancer Center.
MD Anderson, through its Shared Governance Committee, is moving away from an “autocratic” structure, said Julie Izzo, chair of the Faculty Senate and an associate professor in Translational Molecular Pathology at MD Anderson Cancer Center.
Ronald DePinho, the fourth president of the Houston cancer hospital, resigned March 20 after leading the institution for over five years.
“You asked me what went wrong, and as I reflect, I think that culture matters. It matters a lot,” Izzo said to The Cancer Letter. “Over the past five years, we did have a clash of cultures, and it is important that there is an onboarding plan for the next president, and the onboarding plan must involve the MD Anderson community. That’s really necessary.”
The Shared Governance Committee was formed in response to faculty unrest during the DePinho years. Described as “the foremost advisory body to the president,” the committee includes top executives, division heads, department chairs, and leadership of the Faculty Senate.
Continue reading Faculty Senate Chair Julie Izzo: MD Anderson has evolved beyond “autocratic structure”
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.